Cordis brings two new catheters to U.S. market
Cordis, a subsidiary of Johnson & Johnson, has introduced its Fire Star Rx PTCA Dilatation Catheter and its Dura Star Rx PTCA Dilatation Catheter into the U.S. market.
The U.S. FDA approved the commercialization of these products in late August.
According to the Miami Lakes, Fla.-based Cordis, the Fire Star balloon features a low pre-dilatation profile and the Dura Star balloon is suited for use with both drug-eluting and bare metal balloon-expandable stents.
Both balloons will be offered to catheterization laboratories and interventional cardiologists on Oct. 15.
The U.S. FDA approved the commercialization of these products in late August.
According to the Miami Lakes, Fla.-based Cordis, the Fire Star balloon features a low pre-dilatation profile and the Dura Star balloon is suited for use with both drug-eluting and bare metal balloon-expandable stents.
Both balloons will be offered to catheterization laboratories and interventional cardiologists on Oct. 15.